- TRADE NAME: Emflaza (Marathon)
- INDICATIONS: Duchenne muscular dystrophy
- CLASS: Corticosteroid / Glucocorticoid
- HALF-LIFE: N/A
- FDA APPROVAL DATE: 02/09/2017
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Carbamazepine, Clarithromycin, Diltiazem, Efavirenz, Fluconazole, Grapefruit Juice, Live vaccines, Pancuronium, Phenytoin, Rifampin, Verapamil - PREGNANCY: Should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 02/12/2024
